Your browser doesn't support javascript.
loading
Melanocyte-specific CD49a+ CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
Yokoi, Kazunori; Watanabe, Rei; Kume, Miki; Yamane, Saki; Tanaka, Atsushi; Fujimoto, Manabu; Tanemura, Atsushi.
Affiliation
  • Yokoi K; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Watanabe R; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kume M; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yamane S; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tanaka A; Department of Experimental Immunology, Immunology Frontier Research Center, Faculty of Medicine, Osaka University, Osaka, Japan.
  • Fujimoto M; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tanemura A; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
J Dermatol ; 50(5): 710-714, 2023 May.
Article in En | MEDLINE | ID: mdl-36514908
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Hypopigmentation Limits: Humans Language: En Journal: J Dermatol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Hypopigmentation Limits: Humans Language: En Journal: J Dermatol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom